Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial - Loibl, Sibylle; Schneeweiss, Andreas (Annals of oncology, 2017)
Published online: 10 November 2016
Gesehen am 12.04.2018